Overview

Efficacy of Nitrous Oxide in OCD: Pilot Study

Status:
Recruiting
Trial end date:
2022-10-01
Target enrollment:
0
Participant gender:
All
Summary
This study investigates whether the commonly used and well-tolerated inhaled anesthetic nitrous oxide can rapidly improve symptoms of OCD.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Stanford University
Collaborator:
Brain & Behavior Research Foundation
Treatments:
Nitrous Oxide
Criteria
Inclusion Criteria:

- Age 18-65

- Primary diagnosis of OCD

- Sufficient severity of OCD symptoms

- Ability to tolerate a treatment-free period

- Capacity to provide informed consent

Exclusion Criteria:

- Psychiatric or medical conditions that make participation unsafe

- Pregnant or nursing females

- Concurrent use of any medications that might increase the risk of participation (e.g.
drug interactions)